European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.

Mission

The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'

Models of Addiction

Published by
EMCDDA

The science of addiction is complicated, and it continues to be a field where the debate over definitions, models, theories, and the most appropriate ways to respond continues. 

EMCDDA's Insight Review provides a critical analysis of the different models of addiction.

Lisbon Addictions 2019

Lisbon, Portugal,

The third European conference on addictive behaviours and dependencies will be held in Lisbon from 23–25 October 2019.

European Drug Report 2018

Published by
European Monitoring Centre on Drugs and Drug Addiction
Publication Date

The European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) has released their latest European Drugs report. 

Covering 30 European countries the report explores drug trends, developments in prevention and treatment, public health issues, supply and drug policy. 

Available in 24 languages the report is free to download from the EMCDDA website: http://www.emcdda.europa.eu/edr2018